Abbott Laboratories (NYSE:ABT) reported third-quarter sales growth of 7% and adjusted earnings-per-share growth of 9%, while announcing plans to separate its nutrition business into an independent publicly traded company through a tax-free distribution to shareholders.
Chairman and Chief Executive
Healthcare product and device company Abbott Laboratories (NYSE:ABT) met Wall Street’s revenue expectations in Q3 2026, with sales up 14.5% year on year to $...
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability ...
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ...
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th...
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ...
Crescent Energy (NYSE:CRGY) said it has agreed to acquire Devon Energy’s Eagle Ford assets for a net purchase price of about $3.85 billion, a transaction the company expects to close in the fourth quarter of 2026 or early 2027, subject to customary conditions and regulatory approvals.
Chief Executi
Many investors forget that the Novelis aluminum supplier factory fire hindered Ford's most profitable product. Now, finally, there's good news, and the automaker can start regaining lost production.
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
